Barclays Analyst Pens Open Letter To Gilead Board And Management

On Friday, Barclays analyst Geoff Meacham veered from his typical approach of addressing clients and chose to speak directly to management at Gilead Sciences, Inc. GILD 0.29%. Meacham chose to structure his latest research note on the pharma giant as a letter to the company, which included five recommendations for ways the company could potentially…

3 Apps That May Be The Snapchat Of The East

Many American investors were excited to get in on the Snap Inc SNAP 2.82% IPO last week. With more than 158 million daily active users, Snapchat is one of the most popular social media platforms in the United States. However, at the moment, the single largest global market is the world is off-limits.